Perindopril, atenolol, and amlodipine prevent aortic ultrastructural changes in rats exposed to ethanol

Medical Science Monitor

Volumn 14, Issue 5, 2008, Pages

  Yokusoglu, Mehmet ^a   Sag, Cemal ^a   Cincik, Mehmet ^a   Uzun, Mehmet ^a   Kayir, Hakan ^a   Koz, Cem ^a   Baykal, Baris ^a   Ozkan, Mustafa ^a   Ozogul, Candan ^b   Baysan, Oben ^a   Uzbay, Ismail Tayfun ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Alcohol consumption; Amlodipine; Aortic ultrastructure; Atenolol; Perindopril

Indexed keywords

ALCOHOL; AMLODIPINE; ATENOLOL; ETHER; PERINDOPRIL; SODIUM CHLORIDE; SUCROSE;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; AORTA INJURY; AORTA WALL; ARTICLE; ASCENDING AORTA; CALORIE; CONTROLLED STUDY; DRUG EFFECT; HEART; MALE; NONHUMAN; RAT; SPECTROPHOTOMETRY; TRANSMISSION ELECTRON MICROSCOPY;

ADRENERGIC BETA-ANTAGONISTS; AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; ATENOLOL; CALCIUM CHANNEL BLOCKERS; ENDOTHELIAL CELLS; ETHANOL; MALE; MICROSCOPY, ELECTRON; PERINDOPRIL; RATS; RATS, WISTAR;

EID: 43549101967     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. O'Brien CP: Drug addiction and drug abuse. In: Hardman JG, Limbird LE, Molinoff PB et al: (eds.) Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill, 1996; 557-75
2. Anderson P, Cremona A, Paton A et al: The risk of alcohol. Addiction, 1993; 88: 1493-508
3. Zakhari S: Vulnerability to cardiac disease. Recent Dev Alcohol, 1991; 9: 225-60
4. Sag C, Yokusoglu M, Cincik M et al: The prevention of myocardial ultrastructural changes by perindopril, atenolol and amlodipine in chronic alcohol administered rats. Pharmacol Res, 2006; 53: 142-48
5. th ed. Philadelphia: Elsevier Saunders, 2005; 973
6. Albano E: Alcohol, oxidative stress and free radical damage. Proc Nutr Soc, 2006; 65: 278-90
7. Yuksel N, Uzbay IT, Karakilic H et al: Increased serum nitrite/nitrate (NOx) and malondialdehyde (MDA) levels during alcohol withdrawal in alcoholic patients. Pharmacopsychiatry, 2005; 38: 95-96
8. th ed., Edinburgh: Churchill Livingstone, 1999; 278-300
9. Dahlof B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis 109 treatment studies. Am J Hypertens, 1992; 5: 95-110
10. Uzbay IT, Kayaalp SO: A Modified liquid diet of chronic ethanol administration. Validation by ethanol withdrawal syndrome in rats. Pharmacol Res, 1995; 32: 37-42
11. Majchrowicz E: Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia, 1975; 43: 1993-96
12. Uzbay IT, Kayaalp SO: Heterogeneity of tolerance developed to effects of ethanol on rotarod and accelerod performances in rats. Alcohol, 1995; 12: 593-95
13. Baysan O, Kaptan K, Erinc K et al: Chronic heavy ethanol consumption is associated with decreased platelet aggregation in rats. Tohoku J Exp Med., 2005; 206: 85-90
14. Uzbay IT, Akarsu ES, Kayaalp SO: Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats. Pharmacol Biochem and Behav, 1994; 49: 969-74
15. Uzbay IT, Erden BF, Tapanyigit EE, Kayaalp SO: Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sciences, 1997; 61: 2197-209
16. Uzbay IT, Usanmaz SE, Tapanyigit EE et al: Dopaminergic and serotonergic alterations in the rat brain during ethanol withdrawal: association with behavioral signs. Drug and Alcohol Dependence, 1998; 53: 39-47
17. Uzbay IT, Usanmaz SE, Akarsu ES: Effects of chronic ethanol administration on serotonin metabolism in the various regions of the rat brain. Neurochemical Research, 2000; 25: 257-62
18. Uzbay IT, Yeşilyurt O, Celik T et al: Effects of agmatine on ethanol withdrawal in rats. Behavioural Brain Research, 2000; 107: 153-59
19. Simoni G, Pastorino C, Perrone R: Screening for abdominal aortic aneurysms and associated risk factors in a general population. Eur J Vasc Endovasc Surg, 1995; 10: 207-10
20. Ross MH, Pawlina W: Histology: a text and atlas with correlated cell and molecular biology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2006; 372-77
21. Factor SM: Intramyocardial small-vessel disease in chronic alcoholism. Am Heart J, 1976; 92: 561-75
22. Fox KM, EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators: Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet, 2003; 362: 782-88
23. Ghiadoni L, Magagna A, Versari D et al: Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension, 2003; 41: 1281-86
24. Orekhov AN, Baldenkov GN, Tertov VV et al: Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells. J. Cardiovasc Pharmacol, 1988; 12(Suppl.6): S66-68
25. Kalenikova EI, Gorodetskaya EA, Zacharova NV et al: Perindopril effects on angiotensin I elimination in lung after experimental myocardial injury induced by intracoronary microembolization in rats. J Cardiovasc Pharmacol, 1998; 32: 608-15
26. Watanabe K, Saito Y, Ma M et al: Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy. J Cardiovasc Pharmacol, 2003; 42(Suppl.1): S105-9
27. Temsah RM, Dyck C, Netticadan T et al: Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart. J Pharmacol Exp Ther, 2000; 293: 15-23
28. Frances C, Nazeyrollas P, Prevost A et al: Role of beta 1- and beta 2-adrenoceptor subtypes in preconditioning against myocardial dysfunction after ischemia and reperfusion. J CardiovascPharmacol, 2003; 41: 396-405
29. Sharifi AM, Schiffrin EL: Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. Am J Hypertens, 1998; 11: 1108-16
30. Sima A, Stancu C, Constantinescu E et al: The hyperlipemic hamster - a model for testing the anti-atherogenic effect of amlodipine. J Cell Mol Med, 2001; 5: 153-62
31. Nayler WG: Amlodipine pretreatment and the ischemic heart. Am J Cardiol, 1989; 64: 65I-70I
32. Yamazaki T, Komuro I, Zou Y et al.: Efficient inhibition of the development of cardiac remodelling by a long-acting calcium antagonist amlodipine. Hypertension, 1998; 31: 32-38
33. Levy BI, Michel JB, Salzmann JL et al: Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res, 1988; 63: 227-39
34. Rolland PH, Charpiot P, Friggi A et al: Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs. Am J Cardiol, 1993; 71: 22E-27E
35. Levy BI, Michel JB, Salzmann JL et al: Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats. Am J Cardiol, 1993; 71: 8E-16E
36. Charpiot P, Rolland PH, Friggi A et al: ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries. Arterioscl Thromb Vas, 1993; 13: 1125-38
37. Fennessy PA, Campbell JH, Campbell GR: An angiotensin converting enzyme inhibitor, perindopril, prevents progression of preformed atherosclerotic lesions in the cholesterol-fed rabbit. Clin Sci (Lond), 1994; 87: 685-91
38. Fennessy PA, Campbell JH, Campbell GR: Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture. Atherosclerosis, 1994; 106: 29-41
39. Brophy C, Tilson JE, Tilson MD: Propranolol delays the formation of aneurysms in the male blotchy mouse. J Surg Res, 1988; 44: 687-89
40. The Propranolol Aneurysm Trial Investigators: The propranolol for small abdominal aortic aneurysms: Results of a randomised trial. J Vasc Surg, 2002; 35: 72-79
41. Ichihara A, Hayashi M, Koura Y et al: Long-term effects of intensive blood-pressure lowering on arterial wall stiffness in hypertensive patients. Am J Hypertens, 2003; 16: 959-65
42. Wozniak B, Musialkiewicz D, Wozniak A et al: Lack of changes in the concentration of thiobarbituric acid-reactive substances (TBARS) and in the activities of erythrocyte antioxidant enzymes in alcohol-dependent patients after detoxification. Med Sci Monit, 2008; 14(1): CR32-36
43. French SW, Wong K, Jui L et al: Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis. Exp Mol Pathol, 1993; 58: 61-75
44. Aydin S, Ozaras R, Uzun H et al: N-acetylcysteine reduced the effect of ethanol on antioxidant system in rat plasma and brain tissue. Tohoku J Exp Med., 2002; 198: 71-77
45. Richard V, Joannides R, Henry JP et al: Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: haemodynamic, biological and structural effects. J Hypertens, 1996; 14: 1447-54
46. Antony I, Lerebours G, Nitenberg A: Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. Circulation, 1996; 94: 3115-22
47. Yoshii T, Iwai M, Li Z et al: Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res, 2006; 29: 457-66
48. Oriz ME, Nunez-Vergara LJ, Squella JA: Relative reactivity of dihydropyridine derivatives to electrogenerated superoxide ion in DMSO solutions: a voltammetric approach. Pharm Res, 2003; 20: 292-96
49. Mak IT, Weglicki WB: Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res, 1988; 63: 262-66
50. Gomes A, Costa D, Lima JL, Fernandes E: Antioxidant activity of betablockers: an effect mediated by scavenging reactive oxygen and nitrogen species? Bioorg Med Chem, 2006; 14: 4568-77